Techno Medical Public Company Limited - Equity Warrant - Laporan Laba Rugi (TTM)

Techno Medical Public Company Limited - Equity Warrant
TH ˙ SET
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Techno Medical Public Company Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 628 632 615 617 675 675 683 689 628 645 656 674 685 697 711 711 726 726 717 717
Change (%) 0.61 -2.65 0.30 9.52 0.00 1.11 0.92 -8.84 2.65 1.77 2.68 1.68 1.69 1.96 -0.02 2.17 0.00 -1.25 0.08
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 378 384 383 379 411 418 426 431 401 414 424 442 453 466 480 482 496 492 481 473
Change (%) 1.57 -0.14 -1.03 8.33 1.81 1.86 1.27 -7.14 3.40 2.25 4.33 2.52 2.73 3.06 0.55 2.88 -0.80 -2.27 -1.60
% of Revenue 60.19 60.76 62.33 61.50 60.83 61.93 62.39 62.60 63.77 64.23 64.53 65.57 66.11 66.79 67.50 67.89 68.36 67.81 67.11 65.98
Gross Operating Profit 250 248 232 237 265 257 257 258 228 231 233 232 232 232 231 228 230 234 236 244
Change (%) -0.84 -6.53 2.50 11.41 -2.80 -0.10 0.35 -11.68 1.33 0.92 -0.32 0.10 -0.34 -0.24 -1.21 0.68 1.74 0.89 3.51
% of Revenue 39.81 39.24 37.67 38.50 39.17 38.07 37.61 37.40 36.23 35.77 35.47 34.43 33.89 33.21 32.50 32.11 31.64 32.19 32.89 34.02
SG&A 183 183 189 193 203 202 198 200 200 212 215 215 222 225 231 238 235 230 219 214
Change (%) 0.01 2.98 2.20 5.38 -0.56 -1.81 0.85 0.03 6.02 1.22 -0.04 3.46 1.15 2.87 3.06 -1.18 -2.46 -4.49 -2.36
% of Revenue 29.17 29.00 30.68 31.26 30.08 29.91 29.04 29.02 31.84 32.89 32.71 31.84 32.40 32.23 32.51 33.52 32.41 31.62 30.58 29.84
R&D
Change (%)
% of Revenue
OpEx 561 567 572 572 614 620 624 632 601 626 638 657 675 690 711 721 732 722 700 688
Change (%) 1.06 0.87 0.04 7.34 1.02 0.66 1.14 -4.87 4.28 1.90 2.86 2.83 2.21 3.00 1.37 1.53 -1.33 -2.97 -1.84
% of Revenue 89.36 89.76 93.00 92.76 90.91 91.84 91.43 91.63 95.61 97.12 97.24 97.41 98.51 99.01 100.02 101.41 100.77 99.43 97.69 95.82
Operating Income 67 65 43 45 61 55 59 58 28 19 18 17 10 7 -0 -10 -6 4 17 30
Change (%) -3.16 -33.48 3.81 37.42 -10.20 6.14 -1.34 -52.23 -32.70 -2.43 -3.65 -41.33 -32.81 -101.84 7,817.82 -43.84 -174.20 297.27 81.23
% of Revenue 10.64 10.24 7.00 7.24 9.09 8.16 8.57 8.37 4.39 2.88 2.76 2.59 1.49 0.99 -0.02 -1.41 -0.77 0.57 2.31 4.18
Interest Expense -8 -8 -7 -6 -5 -5 -5 -5 -5 -6 -9 -11 -13 -16 -17 -18 -20 -20 -18 -18
Change (%) -2.01 -8.02 -17.78 -7.99 -5.19 0.04 8.65 0.66 14.14 38.54 20.86 23.54 20.08 8.43 6.89 10.95 -0.36 -8.15 -4.24
% of Revenue -1.24 -1.21 -1.14 -0.93 -0.78 -0.74 -0.74 -0.79 -0.87 -0.97 -1.32 -1.56 -1.89 -2.24 -2.38 -2.54 -2.76 -2.75 -2.56 -2.45
Net Income 41 41 29 22 34 30 36 41 15 13 12 9 3 -4 -15 -23 -22 -22 -9 4
Change (%) -0.87 -29.83 -22.22 53.73 -11.50 18.20 12.55 -63.01 -13.46 -7.92 -27.18 -69.98 -271.56 236.04 51.60 -3.60 -1.76 -56.40 -147.41
% of Revenue 6.60 6.50 4.69 3.64 5.10 4.52 5.28 5.89 2.39 2.01 1.82 1.29 0.38 -0.64 -2.12 -3.22 -3.03 -2.98 -1.32 0.62

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista